Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Aptamer anchored nano-architectures for treatment of drug resistant cancer
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-FDP-010
- By: KESHARWANI, Prashant (Central Drug Research Institute, Lucknow, Pharmaceutics and Pharmacokinetics)
- Co-author(s): Prashant Kesharwani
- Abstract:
Background
Despite numerous advances in surgical treatment, chemotherapy and moleculartargeted agents for NSCLC, metastasis and multidrug resistance are still major causes forfailures in treating lung cancer patients[3]. Thus, it is highly desirable to develop new therapeuticapproaches beyond conventional treatment for NSCLCDespite
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023